What are Acadia Pharmaceuticals's profit margins?

Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.

Where do Acadia Pharmaceuticals's ratios come from?

Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Acadia Pharmaceuticals ACAD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	91.5%-0.2pp	91.7%-0.2pp	91.9%-0.1pp	92%-0.1pp	92%+0.6pp
Operating margin	7.4%-2.4pp	9.8%-13.2pp	23%-0.2pp	23.2%-0.3pp	23.6%-0.5pp
Net margin	34.3%-2.2pp	36.5%+11.5pp	24.9%+3.1pp	21.8%-1.2pp	23%-0.7pp
EBITDA margin	8.5%-2.4pp	10.9%-13.5pp	24.4%-0.2pp	24.6%-0.3pp	24.9%-0.8pp
Returns
Return on equity	37.3%-2.6pp	39.9%+4.9pp	35%+1.8pp	33.2%-4.1pp	37.2%-1.7pp
Return on assets	27.4%-1.0pp	28.4%+5.8pp	22.6%+1.9pp	20.8%-2.3pp	23%-0.4pp
Return on invested capital	10%-3.4pp	13.4%-25.4pp	38.8%+0.4pp	38.4%-5.6pp	44%-8.9pp
Efficiency
Asset turnover	0.8×0.0×	0.8×-0.1×	0.9×0.0×	1×-0.1×	1×0.0×
Liquidity
Current ratio	3.6×-0.2×	3.8×+0.8×	3×+0.1×	2.9×0.0×	2.9×+0.5×
Quick ratio	3.6×-0.2×	3.8×+0.8×	3×+0.1×	2.9×+0.1×	2.8×+0.5×
Cash ratio	0.9×+0.3×	0.6×-0.1×	0.7×0.0×	0.8×0.0×	0.7×-0.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.5×-1.4×	-1.1×-0.3×	-0.8×0.0×	-0.8×-0.1×	-0.7×+0.4×
Interest coverage	2.5×-0.8×	3.3×-4.6×	7.9×-0.3×	8.2×-0.2×	8.4×-0.6×
Per Share
Book value per share	$7.230.0%	$7.22+34.4%	$5.38+10.3%	$4.88+6.8%	$4.56+3.6%
Valuation
Market capitalization	$3.8B-16.0%	$4.52B+25.5%	$3.6B-4.0%	$3.75B+35.4%	$2.77B-9.3%
Enterprise value	$3.56B-18.9%	$4.39B+29.3%	$3.4B-4.4%	$3.55B+36.2%	$2.61B-6.4%
Price / earnings	10.1×-1.5×	11.6×-2.2×	13.8×-3.1×	16.9×+4.8×	12.1×-1.4×
Price / sales	3.5×-0.8×	4.2×+0.8×	3.4×-0.2×	3.7×+0.9×	2.8×-0.4×
Price / book	3×-0.6×	3.7×-0.2×	3.9×-0.6×	4.6×+0.9×	3.6×-0.5×
EV / EBITDA	38.4×+0.8×	37.7×+24.4×	13.3×-0.9×	14.2×+3.7×	10.5×-0.8×
EV / sales	3.3×-0.8×	4.1×+0.9×	3.2×-0.2×	3.5×+0.9×	2.6×-0.3×
Earnings yield	9.9%+1.2pp	8.7%+1.4pp	7.3%+1.3pp	5.9%-2.3pp	8.3%+0.8pp
PEG ratio	0.2×0.0×	0.2×0.0×	0.1×+0.1×	0×—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Acadia Pharmaceuticals's profit margins?: Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.
Where do Acadia Pharmaceuticals's ratios come from?: Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.